Back to search

University of British Columbia

Biomarkers of acute and chronic human heart allograft rejection

Abstract

dc:description

Background: Cardiac transplantation is considered the primary therapy for patients with end-stage heart failure. However, the detection of chronic cardiac allograft rejection (expressed as cardiac allograft vasculopathy; CAV) remains an important unsettled issue in cardiac transplantation. The current gold standards for the diagnosis and monitoring of acute rejection and CAV are invasive in nature with risk for complications. From a clinical perspective, more accurate, minimally-invasive alternatives are clearly desirable. The goal of my thesis is to identify biomarkers of human heart allograft rejection, and assess their potential clinical utility and biological implications in the respective disease contexts. Central hypothesis: Peripheral blood-derived molecular biomarker panels provide a means for sensitive and specific diagnosis of acute and chronic cardiac allograft rejection, as well as helping to gain insight into the underlying mechanisms of rejection. Methods: Genomic biomarkers of acute cardiac allograft rejection (AR) and proteomic biomarkers of cardiac allograft vasculopathy (CAV) were identified via Affymetrix microarray analysis of whole blood samples and iTRAQ proteomic analysis of plasma samples, respectively, from cardiac transplant patients. From the genes differentially expressed between AR vs. Non-rejectors (NR), and differentially expressed proteins between CAV and Non-significant CAV (Non-CAV) subjects, biomarkers panels for AR and CAV were generated using classification methods. AR and CAV biomarkers were further analyzed for their biological implications using bioinformatical tools. Results: Microarray comparison between the AR and NR subjects revealed over 1000 differentially expressed genes, many of which that were associated with cellular functions involved in innate and humoral immunity. The 12-gene biomarker panel generated based on the differentially expressed candidates demonstrated 83% sensitivity and 100% specificity. Proteomic analysis of CAV versus Non-CAV plasma samples ultimately lead to the generation of an 18-protein biomarker panel which demonstrated 80% sensitivity and 89% specificity for CAV.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pathology and Laboratory Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lin, David Chia-Hsiang

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/43474

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Lin, David Chia-Hsiang. Biomarkers of acute and chronic human heart allograft rejection. doctoral thesis, University of British Columbia, 2012. http://hdl.handle.net/2429/43474